Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Asymptomatic Infections D058345 1 associated lipids
Trichiasis D058457 1 associated lipids
Granulomatous Mastitis D058890 1 associated lipids
Reproductive Tract Infections D060737 1 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Tick Bites D064927 1 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Ovetchkine P and Cohen R Shortened course of antibacterial therapy for acute otitis media. 2003 Paediatr Drugs pmid:12529165
Arrieta A et al. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. 2003 Antimicrob. Agents Chemother. pmid:14506028
Debremaeker D et al. Analysis of unknown compounds in azithromycin bulk samples with liquid chromatography coupled to ion trap mass spectrometry. 2003 Rapid Commun. Mass Spectrom. pmid:12569445
Mehta CL Arcanobacterium haemolyticum. 2003 J. Am. Acad. Dermatol. pmid:12582410
Kwun WH et al. Effect of azithromycin in the treartment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. 2003 Transplant. Proc. pmid:12591416
Dobbin CJ and Bye PT Adults with cystic fibrosis: meeting the challenge! 2003 Intern Med J pmid:14656234
Peric M et al. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. 2003 Antimicrob. Agents Chemother. pmid:12604536
Korppi M Community-acquired pneumonia in children: issues in optimizing antibacterial treatment. 2003 Paediatr Drugs pmid:14658923
Seral C et al. Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages. 2003 Antimicrob. Agents Chemother. pmid:12604540
Nieuwenhuis RF et al. Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin. 2003 Sex Transm Infect pmid:14663119
Pichichero ME et al. Azithromycin for the treatment of pertussis. 2003 Pediatr. Infect. Dis. J. pmid:14515842
Nafar M et al. A comparison between the efficacy of systemic and local azithromycin therapy in treatment of cyclosporine induced gingival overgrowth in kidney transplant patients. 2003 Transplant. Proc. pmid:14612094
Plouffe JF et al. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. 2003 Clin. Infect. Dis. pmid:14614670
Matsunaga N et al. A case of QT-interval prolongation precipitated by azithromycin. 2003 N. Z. Med. J. pmid:14615808
Suskova VS et al. [Immuno-modulating properties of a macrolide antibiotic "Z-factor"]. 2003 Antibiot. Khimioter. pmid:15002174
Imbert P et al. Eradication of multiresistant Salmonella Hadar convalescent-phase carriage with azithromycin. 2003 Clin. Microbiol. Infect. pmid:14616738
Pisarev VV et al. [Comparative study of azithromycin pharmacokinetics in healthy volunteers in open cross randomized procedure]. 2003 Antibiot. Khimioter. pmid:15004973
Szpakowski M and Szawłowski A [Azithromycin (Sumamed) administration in empiric treatment of nosocomial pneumonia in upper digestive tract cancer patients]. 2003 Prz. Lek. pmid:14575010
Mandić Z et al. Electrochemical oxidation of azithromycin and its derivatives. 2003 J Pharm Biomed Anal pmid:14623590
Muhlestein JB Antibiotic treatment of atherosclerosis. 2003 Curr. Opin. Lipidol. pmid:14624138
Theaudin M et al. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management]. 2003 J Fr Ophtalmol pmid:14631276
Odemis E et al. Azithromycin-induced leukocytoclastic vasculitis. 2003 J. Rheumatol. pmid:14528532
Al-Belasy FA and Hairam AR The efficacy of azithromycin in the treatment of acute infraorbital space infection. 2003 J. Oral Maxillofac. Surg. pmid:12618970
Schultz KD and Oermann CM Treatment of cast bronchitis with low-dose oral azithromycin. 2003 Pediatr. Pulmonol. pmid:12526076
Ewald DP et al. An evaluation of a SAFE-style trachoma control program in Central Australia. 2003 Med. J. Aust. pmid:12526724
Rodvold KA et al. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults. 2003 Antimicrob. Agents Chemother. pmid:12878504
Gryglicka B et al. Evaluation of an anti-chlamydial antibiotic therapy influence on asthma patients. 2003 Ann Univ Mariae Curie Sklodowska Med pmid:15315030
Dunne MW et al. Efficacy of single-dose azithromycin in treatment of acute otitis media in children after a baseline tympanocentesis. 2003 Antimicrob. Agents Chemother. pmid:12878537
Ohsaki Y et al. Alterations in penicillin binding protein gene of Streptococcus pneumoniae and their correlation with susceptibility patterns. 2003 Int. J. Antimicrob. Agents pmid:12927954
Zhou LQ et al. [Detection of bacterial 16S rRAN gene in EPS of men with chronic pelvic pain syndrome and its clinical significance]. 2003 Zhonghua Nan Ke Xue pmid:12931366
Batt SL et al. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae. 2003 Antimicrob. Agents Chemother. pmid:12936971
Henry DC et al. Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. 2003 Antimicrob. Agents Chemother. pmid:12936972
Falk L et al. Tetracycline treatment does not eradicate Mycoplasma genitalium. 2003 Sex Transm Infect pmid:12902584
Nigović B and Simunić B Voltammetric assay of azithromycin in pharmaceutical dosage forms. 2003 J Pharm Biomed Anal pmid:12852463
Strachan D et al. Is oral azithromycin effective for the treatment of cyclosporine-induced gingival hyperplasia in cardiac transplant recipients? 2003 J Clin Pharm Ther pmid:12911686
Sosa J et al. High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998. 2003 Sex Transm Dis pmid:12916137
Ioannidis J and Wilkinson D HIV: opportunistic infections. 2003 Clin Evid pmid:15366175
Sahin-Hodoglugil NN et al. A comparison of cost-effectiveness of three protocols for diagnosis and treatment of gonococcal and chlamydial infections in women in Africa. 2003 Sex Transm Dis pmid:12916139
Gologan R et al. Multiple myeloma in remission complicated by bone marrow granulomas. 2003 Rom J Intern Med pmid:15526516
Kogan R et al. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. 2003 Pediatr. Pulmonol. pmid:12526069
Crum NF et al. Halting a pneumococcal pneumonia outbreak among United States Marine Corps trainees. 2003 Am J Prev Med pmid:12880877
Bhattacharya MK et al. Azithromycin in the treatment of cholera in children. 2003 Acta Paediatr. pmid:12856976
Enomoto T et al. [Azithromycin therapy for patients with intractable diffuse panbronchiolitis]. 2003 Jpn J Antibiot pmid:14679738
Tateda K et al. [Effects of azithromycin on pathogenic bacteria]. 2003 Jpn J Antibiot pmid:14679740
Shimizu T et al. [Effect of azithromycin on mucus secretion from nasal epithelium]. 2003 Jpn J Antibiot pmid:14679741
Taira M et al. [Effect of azithromycin on Cl ion transport in airway epithelial cells]. 2003 Jpn J Antibiot pmid:14679742
Sakata N et al. [Influence of clarithromycin and azithromycin on cell cycle of neoplasms]. 2003 Jpn J Antibiot pmid:14679743
Bowler SD Effect of long-term treatment with azithromycin on disease parameters in cystic fibrosis. 2003 Jpn J Antibiot pmid:14679744
Malhotra M et al. Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. 2003 Indian J Med Sci pmid:14701947
Derelle J [Anti-inflammatory therapy in cystic fibrosis]. 2003 Arch Pediatr pmid:14671937
Lederman HM et al. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. 2003 J. Infect. Dis. pmid:14673757
Kumaresan JA and Mecaskey JW The global elimination of blinding trachoma: progress and promise. 2003 Am. J. Trop. Med. Hyg. pmid:14692677
Favre-Bonté S et al. Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. 2003 J. Antimicrob. Chemother. pmid:12951348
Ramsey PS et al. Maternal and transplacental pharmacokinetics of azithromycin. 2003 Am. J. Obstet. Gynecol. pmid:12634646
Cercek B et al. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial. 2003 Lancet pmid:12642046
Anagnostopoulos GK et al. Omeprazole plus azithromycin and either amoxicillin or tinidazole for eradication of Helicobacter pylori infection. 2003 J. Clin. Gastroenterol. pmid:12642739
Lynch M et al. Azithromycin treatment coverage in Tanzanian children using community volunteers. 2003 Ophthalmic Epidemiol pmid:12815491
Cone LA et al. Delirium in the elderly resulting from azithromycin therapy. 2003 Surg Neurol pmid:12826358
Hanada H et al. Infection of human fibroblast-like synovial cells with Chlamydia trachomatis results in persistent infection and interleukin-6 production. 2003 Microb. Pathog. pmid:12623273
Salcedo Posadas A et al. [Complementary therapies in cystic fibrosis: evidence of therapeutic benefits and treatment recommendations]. 2003 An Pediatr (Barc) pmid:12628117
Amsden GW et al. Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis. 2003 Chest pmid:12628877
Kuvin JT et al. Effect of short-term antibiotic treatment on Chlamydia pneumoniae and peripheral endothelial function. 2003 Am. J. Cardiol. pmid:12633811
Jang D et al. Correlation between culture testing of swabs and ligase chain reaction of first void urine from patients recently treated for Chlamydia trachomatis. 2003 Sex Transm Infect pmid:12794211
Andrews WW et al. Randomized clinical trial of extended spectrum antibiotic prophylaxis with coverage for Ureaplasma urealyticum to reduce post-cesarean delivery endometritis. 2003 Obstet Gynecol pmid:12798523
Iakovlev SV and Ukhin SA [Azithromycin: general properties and regimen optimization based on pharmacokinetic and pharmacological parameters]. 2003 Antibiot. Khimioter. pmid:12803047
Tyteca D et al. The macrolide antibiotic azithromycin interacts with lipids and affects membrane organization and fluidity: studies on Langmuir-Blodgett monolayers, liposomes and J774 macrophages. 2003 J. Membr. Biol. pmid:12820665
Bachmann K et al. Influence of a 3-day regimen of azithromycin on the disposition kinetics of cyclosporine A in stable renal transplant patients. 2003 Pharmacol. Res. pmid:12742010
Sánchez F et al. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia? 2003 Clin. Infect. Dis. pmid:12746768
Malcolm C and Marrie TJ Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting. 2003 Arch. Intern. Med. pmid:12695270
Muñoz B et al. Antibiotic dosage in trachoma control programs: height as a surrogate for weight in children. 2003 Invest. Ophthalmol. Vis. Sci. pmid:12657580
Gibb AM et al. Should we offer antibiotic prophylaxis post sexual assault? 2003 Int J STD AIDS pmid:12662387
Castaldo RS et al. A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease. 2003 Clin Ther pmid:12749513
Seral C et al. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus. 2003 J. Antimicrob. Chemother. pmid:12697643
Faa AG et al. Scrub typhus in the Torres Strait islands of north Queensland, Australia. 2003 Emerging Infect. Dis. pmid:12702230
Hunter RP et al. Azithromycin metabolite identification in plasma, bile, and tissues of the ball python (Python regius). 2003 J. Vet. Pharmacol. Ther. pmid:12667181
Putnam SD et al. Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea. 2003 Diagn. Microbiol. Infect. Dis. pmid:14711482
Gerhardt SG et al. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. 2003 Am. J. Respir. Crit. Care Med. pmid:12672648
Schilling F [SAPHO syndrome. A contribution to discussion]. 2003 Wien. Klin. Wochenschr. pmid:12674695
Bird M et al. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas? 2003 J. Infect. Dis. pmid:12721948
Yoshida H and Kusaba N [Cat scratch disease]. 2003 Nippon Rinsho pmid:12722263
Guchev IA et al. [Prophylaxis of pneumonia occurring outside the hospital in organized groups]. 2003 Voen Med Zh pmid:12722363
Yamaguchi H et al. Chlamydia pneumoniae resists antibiotics in lymphocytes. 2003 Antimicrob. Agents Chemother. pmid:12760877
Jacks SS et al. In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials. 2003 Antimicrob. Agents Chemother. pmid:12709351
Hoban DJ et al. Comparative in vitro surveillance of amoxicillin-clavulanic acid and four oral comparators against 21232 clinical isolates from europe. 2003 Eur. J. Clin. Microbiol. Infect. Dis. pmid:12709842
Faber M et al. [Comparative analysis of the effectiveness and costs of azithromycin and cefoperazone treatment of patients during COPD exacerbation]. 2003 Pol. Merkur. Lekarski pmid:12712826
Basualdo W and Arbo A Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children. 2003 Pediatr. Infect. Dis. J. pmid:12712971
Fernández-Cuenca F et al. In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii. 2003 Chemotherapy pmid:12714805
Goswick SM and Brenner GM Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. 2003 Antimicrob. Agents Chemother. pmid:12543653
Hoffman HL et al. Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model. 2003 Antimicrob. Agents Chemother. pmid:12543686
Javaloy J et al. Follicular conjunctivitis caused by Chlamydia trachomatis in an infant Saharan population: molecular and clinical diagnosis. 2003 Br J Ophthalmol pmid:12543737
Gaynor BD et al. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year. 2003 Br J Ophthalmol pmid:12543738
Niv Y and Abuksis G Survey of the opinions, knowledge and practices of surgeons and internists regarding Helicobacter pylori test-and-treat policy. 2003 J. Clin. Gastroenterol. pmid:12544197
Sanchez JL et al. An outbreak of pneumococcal pneumonia among military personnel at high risk: control by low-dose azithromycin postexposure chemoprophylaxis. 2003 Mil Med pmid:12546236
Owen WM et al. Efficacy of azithromycin for the treatment of feline chlamydophilosis. 2003 J. Feline Med. Surg. pmid:14623199
Tanyuksel M et al. Determination of intracellular efficacies of azithromycin against Leishmania major infection in human neutrophils in vitro. 2003 Cell Biochem. Funct. pmid:12579528
Khedr A and Sheha M Quantitative thin-layer chromatographic method of analysis of azithromycin in pure and capsule forms. 2003 J Chromatogr Sci pmid:12597590
Coke RL et al. Pharmacokinetics and tissue concentrations of azithromycin in ball pythons (Python regius). 2003 Am. J. Vet. Res. pmid:12602593
Rekart ML et al. Targeted mass treatment for syphilis with oral azithromycin. 2003 Lancet pmid:12559870
Southern KW and Smyth RL Design of clinical trials in cystic fibrosis. 2003 Lancet pmid:12559892
OÄŸuz F et al. Etiology of acute otitis media in childhood and evaluation of two different protocols of antibiotic therapy: 10 days cefaclor vs. 3 days azitromycin. 2003 Int. J. Pediatr. Otorhinolaryngol. pmid:12560149